DCGI

Corbevax is India's first indigenously developed Receptor Binding Domain (RBD) protein sub-unit vaccine against COVID-19

OxemiaTM (Desidustat) is an oral tablet formulation which is the first-in-India alternative to injectable…

The Drugs Controller General Of India (DCGI) has already approved Covovax for restricted use in emergency situations in adults on…

DCGI has already approved CORBEVAX for restricted use in emergency situation among adults

Various industry experts and subject experts are of opinion that if the government approves recommendation of DTAB and DCGI, it…

Prakash Kumar Singh, Director, Government and Regulatory Affairs, SII, had put in an application to the DCGI on 6th January…

The government is yet to decide on which segment of beneficiaries this new vaccine would be administered

Minister of Health Bharati Pravin Pawar said in Lok Sabha that Covaxin was granted Emergency Use Listing (EUL) by the national…

Dr Reddy’s had submitted its application for approval to the DCGI in December 2021, in addition to data from clinical trial in…

The approval pathways through this route are fast-tracked with certain conditions to enhance the access to certain pharmaceuticals…